|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07H 19/10 | (2006.01) |
| C07H 19/20 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/7072 | (2006.01) |
| (11) | Number of the document | 2794628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12808791.3 |
| Date of filing the European patent application | 2012-12-17 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation | 2017-07-10 |
| (86) | Number | PCT/EP2012/075688 |
| Date | 2012-12-17 |
| (87) | Number | WO 2013/092447 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| 201161577712 P | 2011-12-20 | US |
| (72) |
SMITH, Mark, US
TALAMAS, Francisco Xavier, US
ZHANG, Jing, US
ZHANG, Zhuming, US
|
| (73) |
Riboscience LLC,
3901 Laguna Avenue, Palo Alto, CA 94306,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 4`-Azido-3`-fluoro pakeistieji nukleozido dariniai kaip HCV replikacijos inhibitoriai |
| 4`-AZIDO-3`-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION |
| Payment date | Validity (years) | Amount | |
| 2017-11-22 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-12-17 |